布特林的神经保护潜力:机制和治疗见解
Amulya Dhoddasomanahalli Prabhu1, Prashant Tiwari1, Sonal Dubey1
1College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, 562112, India.
Current drug research reviews
|October 1, 2025
概括
布特林是一种天然化合物,由于其抗氧化和抗炎作用,它对阿尔茨海默氏症和帕金森症等神经退行性疾病具有前途. 然而,生物可用性和大脑透的挑战需要进一步研究临床使用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 自然产品 化学 化学
背景情况:
- 布特林是一种来自Butea monosperma的黄类糖化物,具有神经保护性质.
- 它的机制包括调节神经递质,并表现出抗氧化,抗炎和线粒体保护作用.
- 布特林是神经退行性疾病 (如阿尔茨海默氏症和帕金森病) 的潜在治疗候选者.
研究的目的:
- 审查Butrin的机制性见解,临床前证据和治疗视角.
- 评估Butrin在治疗神经退行性疾病中的潜在临床适用性.
- 巩固当前关于Butrin神经保护作用的知识.
主要方法:
- 对Butrin神经保护作用的临床前研究进行了批判性分析.
- 强调机制:氧化应激缓解,神经炎症抑制,神经营养因子增强,线粒体完整性保护.
- 探索临床翻译限制和新兴药物输送策略.
主要成果:
- 临床前数据显示,布特林可以抵消刺激毒性和蛋白质聚合,这是神经退行症的关键.
- 布特林减轻神经病理过程,并与其他药物表现出协同效应.
- 低生物利用率和有限的血脑屏障透是临床应用的重要障碍.
结论:
- 由于吸收问题和低于最佳的药理动力学,Butrin的临床转化受到阻碍.
- 纳米载体系统,药物重新定位和组合疗法可能会提高疗效.
- 进一步的临床试验和先进的输送系统对于实现butrin在神经退行性疾病中的潜力至关重要.
相关概念视频
01:26Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
01:21Pharmacodynamics: Overview and Principles
2.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.8K
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K